Insider · CIK 0001190642
EDWARDS JEFFREY L
Reports to the SEC for 5 companies · SAN FRANCISCO, CA
Transactions
50
Companies
5
Filings
12
CIK
0001190642
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-06-12 | KYNBKYNTRA BIO, INC. · Stock Option (Right to Buy)A Award | — |
| 2026-04-21 | BIOBIO-RAD LABORATORIES, INC. · Restricted Stock UnitsM Exercise/Conversion | — |
| 2026-04-21 | BIOBIO-RAD LABORATORIES, INC. · Restricted Stock UnitsA Award | — |
| 2026-04-21 | BIOBIO-RAD LABORATORIES, INC.M Exercise/Conversion | — |
| 2025-06-04 | KYNBKYNTRA BIO, INC. · Stock Option (Right to Buy)A Award | — |
| 2025-04-22 | BIOBIO-RAD LABORATORIES, INC. · Restricted Stock UnitsM Exercise/Conversion | — |
| 2025-04-22 | BIOBIO-RAD LABORATORIES, INC. · Restricted Stock UnitsA Award | — |
| 2025-04-22 | BIOBIO-RAD LABORATORIES, INC.M Exercise/Conversion | — |
| 2024-09-06 | BIOBIO-RAD LABORATORIES, INC. · Restricted Stock UnitsA Award | — |
| 2024-07-08 | LFCRLIFECORE BIOMEDICAL, INC. \DE\A Award | — |
| 2024-06-20 | CLSDQClearside Biomedical, Inc. · Stock Option (right to buy)A Award | — |
| 2024-06-05 | KYNBKYNTRA BIO, INC. · Stock Option (Right to Buy)A Award | — |
| 2024-02-01 | LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitM Exercise/Conversion | — |
| 2024-02-01 | LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion | — |
| 2023-06-22 | CLSDQClearside Biomedical, Inc. · Stock Option (right to buy)A Award | — |
| 2023-06-09 | KYNBKYNTRA BIO, INC.S Sale | −$54.7K |
| 2023-06-09 | KYNBKYNTRA BIO, INC.S Sale | −$81K |
| 2023-06-07 | KYNBKYNTRA BIO, INC.A Award | — |
| 2023-06-07 | KYNBKYNTRA BIO, INC. · Stock Option (Right to Buy)A Award | — |
| 2023-06-01 | LFCRLIFECORE BIOMEDICAL, INC. \DE\A Award | — |
| 2023-05-31 | LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion | — |
| 2023-05-31 | LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitM Exercise/Conversion | — |
| 2023-02-01 | LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitA Award | — |
| 2022-06-22 | CLSDQClearside Biomedical, Inc. · Stock Option (right to buy)A Award | — |
| 2022-06-16 | KYNBKYNTRA BIO, INC.A Award | — |
| 2022-06-16 | KYNBKYNTRA BIO, INC. · Stock Option (Right to Buy)A Award | — |
| 2022-06-04 | LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitM Exercise/Conversion | −$67.1K |
| 2022-06-04 | LFCRLIFECORE BIOMEDICAL, INC. \DE\A Award | +$67.1K |
| 2022-05-31 | LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitA Award | — |
| 2021-10-14 | LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitM Exercise/Conversion | −$52.7K |
| 2021-10-14 | LFCRLIFECORE BIOMEDICAL, INC. \DE\A Award | +$52.7K |
| 2021-06-10 | CLSDQClearside Biomedical, Inc. · Stock Option (right to buy)A Award | — |
| 2021-06-04 | LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitA Award | — |
| 2021-05-26 | KYNBKYNTRA BIO, INC. · Stock Option (Right to Buy)A Award | — |
| 2021-05-26 | KYNBKYNTRA BIO, INC.A Award | — |
| 2020-10-14 | LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitA Award | — |
| 2020-06-18 | CLSDQClearside Biomedical, Inc. · Stock Option (right to buy)A Award | — |
| 2020-06-04 | KYNBKYNTRA BIO, INC. · Stock Option (Right to Buy)A Award | — |
| 2020-06-04 | KYNBKYNTRA BIO, INC.A Award | — |
| 2019-06-20 | CLSDQClearside Biomedical, Inc. · Stock Option (right to buy)A Award | — |
| 2019-06-05 | KYNBKYNTRA BIO, INC.A Award | — |
| 2019-06-05 | KYNBKYNTRA BIO, INC. · Stock Option (Right to Buy)A Award | — |
| 2018-09-26 | CLSDQClearside Biomedical, Inc. · Stock Option (right to buy)A Award | — |
| 2018-06-05 | KYNBKYNTRA BIO, INC. · Stock Option (Right to Buy)A Award | — |
| 2018-06-05 | KYNBKYNTRA BIO, INC.A Award | — |
| 2017-06-07 | KYNBKYNTRA BIO, INC. · Stock Option (Right to Buy)A Award | — |
| 2016-06-08 | KYNBKYNTRA BIO, INC. · Stock Option (Right to Buy)A Award | — |
| 2015-10-28 | KYNBKYNTRA BIO, INC. · Stock Option (Right to Buy)A Award | — |
| 2015-10-28 | KYNBKYNTRA BIO, INC. · Stock Option (Right to Buy)A Award | — |
| 2014-02-21 | ALLERGAN INCEmployee Stock Option (Right to Buy)A Award | +$7.36M |
Recent filings
- 4EDWARDS JEFFREY L0001190642-26-000004SEC(opens sec.gov)
- 4EDWARDS JEFFREY L0001190642-26-000002SEC(opens sec.gov)
- 4EDWARDS JEFFREY L0001415889-25-015987SEC(opens sec.gov)
- 4EDWARDS JEFFREY L0001062993-25-007905SEC(opens sec.gov)
- 4EDWARDS JEFFREY L0001062993-24-016370SEC(opens sec.gov)
- 4EDWARDS JEFFREY L0001628280-24-031630SEC(opens sec.gov)
- 4EDWARDS JEFFREY L0001415889-24-017823SEC(opens sec.gov)
- 4EDWARDS JEFFREY L0001415889-24-015856SEC(opens sec.gov)
- 4EDWARDS JEFFREY L0001628280-24-003134SEC(opens sec.gov)
- 4EDWARDS JEFFREY L0001209191-23-039422SEC(opens sec.gov)
- 4EDWARDS JEFFREY L0001209191-23-036076SEC(opens sec.gov)
- 4EDWARDS JEFFREY L0001628280-23-020831SEC(opens sec.gov)
Companies
Address
C/O KYNTRA BIO, INC. 350 BAY STREET, SUITE 110, #6009
SAN FRANCISCO, CA, 94133